Table 4.
Characteristic | Experienced IPV aORa (95% CI) | Perpetrated IPV aORa (95% CI) |
---|---|---|
Dyadic-level | ||
Duration of relationship (≥3 years vs. <3 years) | 1.62 (1.03-2.53) | 1.13 (0.69-1.85) |
Sexual agreement | ||
Closed vs. no agreement | 1.57 (0.91-2.70) | 0.99 (0.54-1.80) |
Open vs. no agreement | 0.89 (0.48-1.67) | 0.65 (0.32-1.31) |
Discordant responses versus no agreement | 1.12 (0.36-3.49) | 0.65 (0.19-2.28) |
Differences in agreement regarding general lifestyle issuesb (continuous) | 1.04 (0.94-1.14) | 0.99 (0.90-1.10) |
Differences in agreement regarding sexual health issuesc (continuous) | 1.04 (0.97-1.12) | 1.03 (0.95-1.11) |
Differences in trust between partnersd (continuous) | 1.03 (0.97-1.09) | 1.06 (0.99-1.13) |
Participant-specific | ||
Sexual orientation | ||
Bisexual vs. gay | 1.33 (0.60-2.96) | 1.38 (0.58-3.28) |
“Other” vs. gay | 0.48 (0.13-1.74) | 0.26 (0.06-1.04) |
Non-prescription drug use or heavy alcohol use in the past 3 monthse (yes vs. no) | 1.12 (0.71-1.77) | 1.62 (0.98-2.67) |
Depressive symptomatologyf (continuous) | 1.13 (1.07-1.19) | 1.11 (1.05-1.17) |
Partner-specific | ||
Sexual orientation | ||
Bisexual vs. gay | 0.91 (0.42-1.99) | 0.60 (0.26-1.39) |
“Other” vs. gay | 0.48 (0.13-1.76) | 0.97 (0.23-4.07) |
Non-prescription drug use or heavy alcohol use in the past 3 monthse (yes vs. no) | 1.30 (0.82-2.05) | 0.81 (0.50-1.32) |
Depressive symptomatologyf (continuous) | 1.07 (1.02-1.13) | 1.04 (0.99-1.09) |
Adjusted for differences in partners’ age, race/ethnicity and highest educational level.
Calculated by taking the absolute difference between the scores for each partner on the 6-item Preferences for General Lifestyle Outcomes Scale. Higher values indicate greater differences in agreement within the relationship.
Calculated by taking the absolute difference between the scores for each partner on the 7-item Preferences for Sexual Health Outcomes Scale. Higher values indicate greater differences in agreement within the relationship.
Calculated by taking the absolute difference between the scores for each partner on the 8-item Dyadic Trust Scale. Higher values indicate greater differences in trust between partners.
Defined as using marijuana (“pot” or “weed”), amyl nitrite (“poppers”), central nervous system depressants (“downers” such as Valium, Ativan or Xanax), opioid analgesics (such as Oxycontin or Percocet), hallucinogens (such as lysergic acid diethylamide or “acid”), 3,4-methylenedioxy-methamphetamine (“ecstasy” or “molly”), club drugs (such as ketamine or “special K”), non-injection amphetamine (“speed”, “crystal meth” or “crank”), injection amphetamine (“speed”, “crystal meth” or “crank”), non-injection cocaine (smoked or snorted), injection cocaine, non-injection heroin (smoked or snorted), injection heroin, or some other non-prescription drug, or consuming ≥6 alcoholic drinks on the same occasion weekly, almost daily, or daily.
Assessed using the 11-item Iowa short form of the Center for Epidemiologic Studies Depression Scale. Higher scores indicate greater levels of depressive symptomatology.